about
Elements modulating the prion species barrier and its passage consequencesImmunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged MiceVertical transmission of bovine spongiform encephalopathy prions evaluated in a transgenic mouse model.Rift valley fever: recent insights into pathogenesis and preventionAn African swine fever virus gene with similarity to the T-lymphocyte surface antigen CD2 mediates hemadsorption.Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice.Chimpanzee Adenovirus Vaccine Provides Multispecies Protection against Rift Valley Fever.A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection.Antigen delivery systems for veterinary vaccine development. Viral-vector based delivery systems.Current strategies for subunit and genetic viral veterinary vaccine development.Understanding Rift Valley fever: contributions of animal models to disease characterization and control.DNA vaccination can break immunological tolerance to PrP in wild-type mice and attenuates prion disease after intracerebral challenge.Pathological Characterization Of IFNAR(-/-) Mice Infected With Bluetongue Virus Serotype 4Priming with DNA plasmids encoding the nucleocapsid protein and glycoprotein precursors from Rift Valley fever virus accelerates the immune responses induced by an attenuated vaccine in sheep.Potential application of silver nanoparticles to control the infectivity of Rift Valley fever virus in vitro and in vivo.Protection against Rift Valley fever virus infection in mice upon administration of interferon-inducing RNA transcripts from the FMDV genome.Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs.Generation and application of monoclonal antibodies against Rift Valley fever virus nucleocapsid protein NP and glycoproteins Gn and Gc.European ring trial to evaluate ELISAs for the diagnosis of infection with Rift Valley fever virus.Detection and identification of Rift Valley fever virus in mosquito vectors by quantitative real-time PCR.Microspheres-prime/rMVA-boost vaccination enhances humoral and cellular immune response in IFNAR(-/-) mice conferring protection against serotypes 1 and 4 of bluetongue virus.DNA vaccination regimes against Schmallenberg virus infection in IFNAR-/- mice suggest two targets for immunization.A DNA vaccine encoding ubiquitinated Rift Valley fever virus nucleoprotein provides consistent immunity and protects IFNAR(-/-) mice upon lethal virus challenge.Experimental infection of young adult European breed sheep with Rift Valley fever virus field isolates.Protection against lethal Rift Valley fever virus (RVFV) infection in transgenic IFNAR(-/-) mice induced by different DNA vaccination regimens.Design and construction of African swine fever virus chimeras incorporating foreign viral epitopes.Vaccines and Vaccination for Veterinary Viral Diseases: A General Overview.High-yield expression of a viral peptide vaccine in transgenic plants.Subclinical bovine spongiform encephalopathy infection in transgenic mice expressing porcine prion protein.Different behavior toward bovine spongiform encephalopathy infection of bovine prion protein transgenic mice with one extra repeat octapeptide insert mutation.Proteinase K enhanced immunoreactivity of the prion protein-specific monoclonal antibody 2A11.Reduced susceptibility to bovine spongiform encephalopathy prions in transgenic mice expressing a bovine PrP with five octapeptide repeats.Early detection of PrPres in BSE-infected bovine PrP transgenic mice.Distribution of the cellular prion protein (PrPC) in brains of livestock and domesticated species.Transgenic mice expressing bovine PrP with a four extra repeat octapeptide insert mutation show a spontaneous, non-transmissible, neurodegenerative disease and an expedited course of BSE infection.Efficacy of different DNA and MVA prime-boost vaccination regimens against a Rift Valley fever virus (RVFV) challenge in sheep 12 weeks following vaccination.Genomics of VirusesAltered lymphocyte homeostasis after oral prion infection in mouseDiscrimination of sheep susceptible and resistant to transmissible spongiform encephalopathies by an haplotype specific monoclonal antibodyModeling Arboviral Infection in Mice Lacking the Interferon Alpha/Beta Receptor
P50
Q28540614-D26CB05F-1AC5-4C46-A616-B5EBA6295BBEQ33622211-953BCB7E-7017-4B07-AC92-53BCD6E6666EQ33843366-A7FC3A31-7038-48A7-A536-A2EA169201E7Q34174444-1F79176C-F635-4A51-AA38-690FA00C39E8Q34322089-E3C3BD38-DB6F-4148-8440-714B79BA4E30Q34529382-4F21D6AB-7768-43C2-BE23-C8F0E7A1087DQ36548980-EC3DEFF9-55EF-40E2-A159-C17635F94159Q37004283-12BF7F25-EDF3-440C-88B5-4FB95CA40DD5Q37288017-DEE5B313-9589-49A2-B8EE-D99F02C4FF80Q37840709-4C0B1F25-8DE8-48F5-A8C0-604A9490394EQ38366135-8B7C2562-486E-497D-8288-8E93BD120BFBQ38761934-60A98831-146F-4504-B7CD-21EE34344A79Q39312045-8DB1AE11-E6DE-41FA-9BB1-B6286FFF1A2CQ39953693-2CCDE396-0771-40F1-A1B4-78FE3828059CQ40114294-7375221E-DC8C-4591-A6B5-9A130643A0C6Q40202028-C2915FAA-5E48-47D4-9756-7C6F9BEDECA5Q40203534-5354DAB5-93EB-4977-8C96-0A75CBC40ABEQ40232418-EE10AD1A-2B68-4EAC-94F8-B29EC6E71346Q40272959-AE16A34B-3368-4B75-AFC4-FAC4A6D389A1Q40279271-9D92F30A-D2E1-4004-BC19-A904E6CCB6CEQ40283047-11EB92CB-1851-4703-A63C-A6A3E6EF8281Q40318622-CF4ECD05-B519-4A94-8704-CEE817FE1EA7Q40325815-B0DED1B0-98F6-4445-9B70-3D4181B3C02EQ40348206-D5BEE94E-A746-49BE-8AA1-E3436CD66F76Q40365121-0DF5C99D-5C7C-440B-A36D-EE8AA689F2F1Q40633098-DAB4F548-FE13-4DB9-A89C-469DD873B39EQ40956505-4F5ABEE8-FE28-4F76-B9C6-049824576923Q44911177-57FC1BB8-36A2-442E-9DAF-F9A322C9AB00Q47428130-61DBD45E-44ED-4331-87AC-DDC98E942E7DQ48002520-3116CE47-C14F-41EC-8C07-DA5A8FBBCABCQ48109848-EDBB4488-ED46-4F57-8670-A035C4A87D6BQ48176261-9EB0DC2D-DA32-4C78-8C5F-21ECA03D17D2Q48351069-6E12A785-4311-48F8-8C05-EC99F95C6538Q48427133-0CBFE86A-24D9-49B2-834F-6EFDEC0F8184Q48715592-D992D0A2-1067-4AA5-A61D-228DBD21CF4AQ50329180-88020B46-74FB-491B-80C3-324351E7338AQ56957751-206069E8-A9C5-4538-83F8-72E736F4F09CQ57261117-77016129-35A0-42B1-8994-45D011E6EAF6Q57261120-C1DC72E1-EC92-4CB7-B21C-8E148E5A951FQ61803865-A7621FA8-8BBA-44F1-A0E2-FB7E3C2B5465
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Alejandro Brun
@ast
Alejandro Brun
@en
Alejandro Brun
@es
Alejandro Brun
@nl
type
label
Alejandro Brun
@ast
Alejandro Brun
@en
Alejandro Brun
@es
Alejandro Brun
@nl
prefLabel
Alejandro Brun
@ast
Alejandro Brun
@en
Alejandro Brun
@es
Alejandro Brun
@nl
P1053
J-9808-2014
P106
P1153
7202745045
7202745069
P21
P31
P3829
P496
0000-0001-7865-538X